AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-88
Results: 1-25/88
RECENT PROGRESS IN THE BIOLOGY OF MULTIPLE-MYELOMA AND FUTURE-DIRECTIONS IN THE TREATMENT
Authors: PICO JL CASTAGNA L BOURHIS JH
Citation: Jl. Pico et al., RECENT PROGRESS IN THE BIOLOGY OF MULTIPLE-MYELOMA AND FUTURE-DIRECTIONS IN THE TREATMENT, HEM CELL TH, 40(2), 1998, pp. 45-61
NEUTROPENIC INFECTIONS - A REVIEW OF THE FRENCH FEBRILE APLASIA STUDY-GROUP TRIALS IN 608 FEBRILE NEUTROPENIC PATIENTS
Authors: MARIE JP VEKHOFF A PICO JL GUY H ANDREMONT A RICHET H
Citation: Jp. Marie et al., NEUTROPENIC INFECTIONS - A REVIEW OF THE FRENCH FEBRILE APLASIA STUDY-GROUP TRIALS IN 608 FEBRILE NEUTROPENIC PATIENTS, Journal of antimicrobial chemotherapy, 41, 1998, pp. 57-64
PROGNOSTIC FACTORS FOR HIGH-DOSE CHEMOTHERAPY (HDCT) AS SALVAGE TREATMENT IN GERM-CELL TUMORS (GCT)
Authors: BEYER J KRAMAR A MANDANAS R LINKESCH W GREINIX A DROZ JP PICO JL DIEHL A BOKEMEYER C SCHMOLL HJ NICHOLS CR EINHORN LH SIEGERT W
Citation: J. Beyer et al., PROGNOSTIC FACTORS FOR HIGH-DOSE CHEMOTHERAPY (HDCT) AS SALVAGE TREATMENT IN GERM-CELL TUMORS (GCT), Bone marrow transplantation, 22, 1998, pp. 16-16
VIP (ETOPOSIDE, IFOSFAMIDE AND CISPLATINUM) AS A SALVAGE INTENSIFICATION PROGRAM IN RELAPSED OR REFRACTORY HODGKINS-DISEASE
Authors: RIBRAG V NASR F BOUHRIS JH BOSQ J BRAULT P GIRINSKY T COSSET JM MUNCK JN CORTI C DECAUDIN D PICO JL HAYAT M CARDE P
Citation: V. Ribrag et al., VIP (ETOPOSIDE, IFOSFAMIDE AND CISPLATINUM) AS A SALVAGE INTENSIFICATION PROGRAM IN RELAPSED OR REFRACTORY HODGKINS-DISEASE, Bone marrow transplantation, 21(10), 1998, pp. 969-974
RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 78 PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AL)IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP
Authors: BLAISE D REIFFERS J ATTAL M STOPPA AM MARIT G HUGUET F MOLINA L PICO JL GABUS R BRANDELY M HERCEND T MARANINCHI D
Citation: D. Blaise et al., RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 78 PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AL)IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP, Bone marrow transplantation, 21, 1998, pp. 368-368
LYMPHOBLASTIC LYMPHOMA (LBL) - WHAT IS THE BEST TIME FOR TRANSPLANTATION (BMT) - A STUDY FROM SFGM
Authors: MILPIED N ATTAL M GISSELBRECHT C MARIT G TANGUY ML PICO JL IFRAH N
Citation: N. Milpied et al., LYMPHOBLASTIC LYMPHOMA (LBL) - WHAT IS THE BEST TIME FOR TRANSPLANTATION (BMT) - A STUDY FROM SFGM, Bone marrow transplantation, 21, 1998, pp. 597-597
SUCCESSFUL DONOR-LYMPHOCYTE-INFUSION (DLI) IN A ATIENT WITH MYELODYSPLASTIC-SYNDROME (MDS) AFTER FAILURE OF T-CELL-DEPLETED BONE-MARROW TRANSPLANTATION (TD-BMT)
Authors: CASTAGNA L ELWESHI A BOURHIS JH RIBRAG V NACCACHE P VANTELON JM BRAULT P PICO JL
Citation: L. Castagna et al., SUCCESSFUL DONOR-LYMPHOCYTE-INFUSION (DLI) IN A ATIENT WITH MYELODYSPLASTIC-SYNDROME (MDS) AFTER FAILURE OF T-CELL-DEPLETED BONE-MARROW TRANSPLANTATION (TD-BMT), British Journal of Haematology, 103(1), 1998, pp. 284-285
RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 130 PATIENTS WITH ACUTE-LEUKEMIA (AL) IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP
Authors: BLAISE D ATTAI M REIFFERS J STOPPA AM HUGUET F MARIT G MOLINA L BELLANGER C PICO JL GABUS R BRANDELY M HERCEND T MARANINCHI D
Citation: D. Blaise et al., RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 130 PATIENTS WITH ACUTE-LEUKEMIA (AL) IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP, British Journal of Haematology, 102(1), 1998, pp. 89-89
LOW SPECIFICITY AND SENSITIVITY OF GA-67 SCAN IN THE EVALUATION OF POST CHEMOTHERAPY MEDIASTINAL RESIDUAL MASSES IN AGGRESSIVE NON-HODGKINS-LYMPHOMA
Authors: ULUSAKARYA A MUNCK JN CASIRAGHI O KOSCIELNY S VANTELON JM DARTEVELLE P GIRINSKY T CARDE P PICO JL HAYAT M
Citation: A. Ulusakarya et al., LOW SPECIFICITY AND SENSITIVITY OF GA-67 SCAN IN THE EVALUATION OF POST CHEMOTHERAPY MEDIASTINAL RESIDUAL MASSES IN AGGRESSIVE NON-HODGKINS-LYMPHOMA, British Journal of Haematology, 102(1), 1998, pp. 246-246
TREATMENT-RELATED DEATHS AND 2ND CANCER RISK AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HODGKINS-DISEASE
Authors: ANDRE M HENRYAMAR M BLAISE D COLOMBAT P FLEURY J MILPIED N CAHN JY PICO JL BASTION Y KUENTZ M NEDELLEC G ATTAL M FERME C GISSELBRECHT C
Citation: M. Andre et al., TREATMENT-RELATED DEATHS AND 2ND CANCER RISK AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HODGKINS-DISEASE, Blood, 92(6), 1998, pp. 1933-1940
PARVOVIRUS B19 ASSOCIATED NEUTROPENIA - TREATMENT WITH RH G-CSF
Authors: GAUTIER E BOURHIS JH BAYLE C CARTRON J PICO JL TCHERNIA G
Citation: E. Gautier et al., PARVOVIRUS B19 ASSOCIATED NEUTROPENIA - TREATMENT WITH RH G-CSF, HEM CELL TH, 39(2), 1997, pp. 85-87
CEFEPIME AMIKACIN VERSUS CEFTAZIDIME/AMIKACIN AS EMPIRICAL THERAPY FOR FEBRILE EPISODES IN NEUTROPENIC PATIENTS - A COMPARATIVE-STUDY/
Authors: CORDONNIER C HERBRECHT R PICO JL GARDEMBAS M DELMER A DELAIN M MOREAU P LADEB S NALET V ROLLIN C GRES JJ
Citation: C. Cordonnier et al., CEFEPIME AMIKACIN VERSUS CEFTAZIDIME/AMIKACIN AS EMPIRICAL THERAPY FOR FEBRILE EPISODES IN NEUTROPENIC PATIENTS - A COMPARATIVE-STUDY/, Clinical infectious diseases, 24(1), 1997, pp. 41-51
MANTLE CELL LYMPHOMAS - CHARACTERISTICS, NATURAL-HISTORY AND PROGNOSTIC FACTORS OF 45 CASES
Authors: DECAUDIN D BOSQ J MUNCK JN BAYLE C KOSCIELNY S BOUDJEMAA S BENNACEUR A VENUAT AM NACCACHE P BENDAHMANE B RIBRAG V CARDE P PICO JL HAYAT M
Citation: D. Decaudin et al., MANTLE CELL LYMPHOMAS - CHARACTERISTICS, NATURAL-HISTORY AND PROGNOSTIC FACTORS OF 45 CASES, Leukemia & lymphoma, 26(5-6), 1997, pp. 539
THE USE OF A SEQUENTIAL HIGH-DOSE RECOMBINANT INTERLEUKIN-2 REGIMEN AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION DOES NOT IMPROVE THE DISEASE-FREE SURVIVAL OF PATIENTS WITH ACUTE-LEUKEMIA TRANSPLANTED IN FIRSTCOMPLETE REMISSION
Authors: BLAISE D ATTAL M PICO JL REIFFERS J STOPPA AM BELLANGER C MOLINA L NEDELLEC G VERNANT JP LEGROS M GABUS R HUGUET F BRANDELY M HERCEND T OLIVE D MARANINCHI D
Citation: D. Blaise et al., THE USE OF A SEQUENTIAL HIGH-DOSE RECOMBINANT INTERLEUKIN-2 REGIMEN AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION DOES NOT IMPROVE THE DISEASE-FREE SURVIVAL OF PATIENTS WITH ACUTE-LEUKEMIA TRANSPLANTED IN FIRSTCOMPLETE REMISSION, Leukemia & lymphoma, 25(5-6), 1997, pp. 469-478
LATE EFFECTS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHILDREN WITH ACUTE MYELOBLASTIC-LEUKEMIA IN FIRST COMPLETE REMISSION - THE IMPACT OF CONDITIONING REGIMEN WITHOUT TOTAL-BODY IRRADIATION - A REPORT FROM THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE
Authors: MICHEL G SOCIE G GEBHARD F BERNAUDIN F THURET I VANNIER JP DEMEOCQ F LEVERGER G PICO JL RUBIE H MECHINAUD F REIFFERS J GRATECOS N TROUSSARD X JOUET JP SIMONIN G GLUCKMAN E MARANINCHI D
Citation: G. Michel et al., LATE EFFECTS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHILDREN WITH ACUTE MYELOBLASTIC-LEUKEMIA IN FIRST COMPLETE REMISSION - THE IMPACT OF CONDITIONING REGIMEN WITHOUT TOTAL-BODY IRRADIATION - A REPORT FROM THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE, Journal of clinical oncology, 15(6), 1997, pp. 2238-2246
REFAIOSPLENIC GAMMA-DELTA T-CELL LYMPHOMA - CLINICAL AND BIOLOGICAL CHARACTERISTICS OF A RECENTLY RECOGNIZED ENTITY WHICH IS FATAL
Authors: GAULARD P BELHADJ K TILLY H CHARLOTTE F LEBLOND V DUVAL C ANGONIN R DECONINCK E PEROT C PICO JL ZAFRANI ES FARCET JP REYES F
Citation: P. Gaulard et al., REFAIOSPLENIC GAMMA-DELTA T-CELL LYMPHOMA - CLINICAL AND BIOLOGICAL CHARACTERISTICS OF A RECENTLY RECOGNIZED ENTITY WHICH IS FATAL, Experimental hematology, 25(8), 1997, pp. 386-386
VALUE OF CYTOMEGALOVIRUS DETECTION BY PCR IN BRONCHOALVEOLAR LAVAGE ROUTINELY PERFORMED IN ASYMPTOMATIC BONE-MARROW RECIPIENTS
Authors: FAJAC A STEPHAN F IBRAHIM A GAUTIER E BERNAUDIN JF PICO JL
Citation: A. Fajac et al., VALUE OF CYTOMEGALOVIRUS DETECTION BY PCR IN BRONCHOALVEOLAR LAVAGE ROUTINELY PERFORMED IN ASYMPTOMATIC BONE-MARROW RECIPIENTS, Bone marrow transplantation, 20(7), 1997, pp. 581-585
EARLY ALLOGENEIC TRANSPLANTATION FAVORABLY INFLUENCES THE OUTCOME OF ADULT PATIENTS SUFFERING FROM ACUTE MYELOID-LEUKEMIA
Authors: JOURDAN E MARANINCHI D REIFFERS J GLUCKMAN E RIO B JOUET JP MICHALLET M MOLINA L ARCHIMBAUD E HAROUSSEAU JL IFRAH N ATTAL M GUILHOT F KUENTZ M GUYOTAT D PICO JL DAURIAC C LEGROS M DREYFUS F BORDIGONI P LEBLOND V GRATECOS N VARET B AUZANNEAU C TILLY H VILMER E BARDOU VJ BLAISE D
Citation: E. Jourdan et al., EARLY ALLOGENEIC TRANSPLANTATION FAVORABLY INFLUENCES THE OUTCOME OF ADULT PATIENTS SUFFERING FROM ACUTE MYELOID-LEUKEMIA, Bone marrow transplantation, 19(9), 1997, pp. 875-881
QUANTITATIVE-ANALYSIS OF T-HELPER-1, T-HELPER-2, AND INFLAMMATORY CYTOKINE EXPRESSION IN PATIENTS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - RELATIONSHIP WITH THE OCCURRENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE
Authors: CARAYOL G BOURHIS JH GUILLARD M BOSQ J PAILLER C CASTAGNA L VERNANT JP PICO JL HAYAT M CHOUAIB S CAIGNARD A
Citation: G. Carayol et al., QUANTITATIVE-ANALYSIS OF T-HELPER-1, T-HELPER-2, AND INFLAMMATORY CYTOKINE EXPRESSION IN PATIENTS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - RELATIONSHIP WITH THE OCCURRENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, Transplantation, 63(9), 1997, pp. 1307-1313
HEPATIC VENOOCCLUSIVE DISEASE AFTER MYELOABLATIVE TREATMENT AND BONE-MARROW TRANSPLANTATION - VALUE OF GRAY-SCALE AND DOPPLER US IN 100 PATIENTS
Authors: LASSAU N LECLERE J AUPERIN A BOURHIS JH HARTMANN O VALTEAUCOUANET D BENHAMOU E BOSQ J IBRAHIM A GIRINSKI T PICO JL ROCHE A
Citation: N. Lassau et al., HEPATIC VENOOCCLUSIVE DISEASE AFTER MYELOABLATIVE TREATMENT AND BONE-MARROW TRANSPLANTATION - VALUE OF GRAY-SCALE AND DOPPLER US IN 100 PATIENTS, Radiology, 204(2), 1997, pp. 545-552
SHOULD CYTOMEGALOVIRUS BE TESTED FOR IN BOTH BLOOD AND BRONCHOALVEOLAR LAVAGE FLUID OF PATIENTS AT A HIGH-RISK OF CMV PNEUMONIA AFTER BONE-MARROW TRANSPLANTATION
Authors: IBRAHIM A GAUTIER E ROITTMANN S BOURHIS JH FAJAC A CHARNOZ I TERRIER P SALORD JM TANCREDE C HAYAT M BERNAUDIN JF PICO JL
Citation: A. Ibrahim et al., SHOULD CYTOMEGALOVIRUS BE TESTED FOR IN BOTH BLOOD AND BRONCHOALVEOLAR LAVAGE FLUID OF PATIENTS AT A HIGH-RISK OF CMV PNEUMONIA AFTER BONE-MARROW TRANSPLANTATION, British Journal of Haematology, 98(1), 1997, pp. 222-227
AVASCULAR NECROSIS OF BONE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - ANALYSIS OF RISK-FACTORS FOR 4388 PATIENTS BY THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE (SFGM)
Authors: SOCIE G CAHN JY CARMELO J VERNANT JP JOUET JP IFRAH N MILPIED N MICHALLET M LIOURE B PICO JL WITZ F MOLINA L FISCHER A BARDOU VJ GLUCKMAN E REIFFERS J
Citation: G. Socie et al., AVASCULAR NECROSIS OF BONE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - ANALYSIS OF RISK-FACTORS FOR 4388 PATIENTS BY THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE (SFGM), British Journal of Haematology, 97(4), 1997, pp. 865-870
PREDICTIVE VALUE OF SERUM P53 ANTIBODIES IN PATIENTS WITH LARGE-CELL LYMPHOMAS RETROSPECTIVE ANALYSIS OF 40 PATIENTS
Authors: GIRINSKY T RIBRAG V BOSQ J KOSCIENLY S MUNCK JN CARDE P PICO JL LUBIN R BOURHIS JH DELARUE P
Citation: T. Girinsky et al., PREDICTIVE VALUE OF SERUM P53 ANTIBODIES IN PATIENTS WITH LARGE-CELL LYMPHOMAS RETROSPECTIVE ANALYSIS OF 40 PATIENTS, Blood, 90(10), 1997, pp. 3896-3896
UNFRACTIONATED PERIPHERAL-BLOOD STEM-CELL AUTOGRAFTS AND CD34-ENRICHED AUTOGRAFTS HAVE SIMILAR LONG-TERM CULTURE INITIATING CAPACITY IN MULTIPLE-MYELOMA()
Authors: TURHAN AG BONNET ML BAYLE C BENNACEURGRISCELLI A VAINCHENKER W BOURHIS JH PICO JL BEAUJEAN F
Citation: Ag. Turhan et al., UNFRACTIONATED PERIPHERAL-BLOOD STEM-CELL AUTOGRAFTS AND CD34-ENRICHED AUTOGRAFTS HAVE SIMILAR LONG-TERM CULTURE INITIATING CAPACITY IN MULTIPLE-MYELOMA(), Blood, 90(10), 1997, pp. 4314-4314
SINGLE-DOSE VERSUS HYPERFRACTIONATED TOTAL-BODY IRRADIATION - A RANDOMIZED STUDY ON 160 PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
Authors: GIRINSKY T BENHAMOU E DHERMAIN F GANENSIA V BAUME D BOURHIS JH COSSET JM BRIOT E BRIDIER A BEAUDRE A PICO JL
Citation: T. Girinsky et al., SINGLE-DOSE VERSUS HYPERFRACTIONATED TOTAL-BODY IRRADIATION - A RANDOMIZED STUDY ON 160 PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, Blood, 90(10), 1997, pp. 4364-4364
Risultati: 1-25 | 26-50 | 51-75 | 76-88